These findings demonstrate that TRUE gene silencing targeted to cyclin D1 leads to inhibition of proliferation of SCC cells and suggest that these sgRNAs may have potential to be therapeutically useful for several cancers including HNSCC. This evidence concerns the gene CCND1 and head and neck squamous cell carcinoma.